04/25/2024 6:15 AM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 5:46 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 3:07 PM | Sage Therapeutics (Filer)
| Form DEF 14A | |
04/24/2024 3:10 PM | Sage Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:13 PM | Sage Therapeutics (Filer)
| Form ARS | |
04/19/2024 7:31 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 5:35 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
03/26/2024 7:34 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 6:49 AM | Sage Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024 6:20 AM | Sage Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 6:09 AM | RTW INVESTMENTS, LP (Filed by) Sage Therapeutics (Subject)
| Form SC 13G | |
02/14/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 4:13 PM | Sage Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/13/2024 5:28 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 5:28 AM | BB BIOTECH AG (Filed by) BB BIOTECH AG (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024 8:49 AM | FMR LLC (Filed by) Sage Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024 9:17 AM | Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
01/31/2024 4:25 PM | Sage Therapeutics (Subject)
| Form SC TO-I/A | |
01/31/2024 3:50 PM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/24/2024 9:04 AM | Sage Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/23/2024 7:13 AM | Sage Therapeutics (Subject)
| Form SC TO-I | |
01/08/2024 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:07 PM | IGUCHI KIMI (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Golumbeski George (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | FRATES JAMES M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | PAUL STEVEN M (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:07 PM | Federer Jessica (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/19/2023 7:30 AM | Sage Therapeutics (Filer)
| Form DEF 14A | |
12/19/2023 7:32 AM | Sage Therapeutics (Filer)
| Form DEFA14A | |
12/08/2023 8:00 AM | Sage Therapeutics (Subject)
| Form SC TO-C | |
12/08/2023 7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
12/08/2023 7:30 AM | Sage Therapeutics (Filer)
| Form PRE 14A | |
11/07/2023 6:39 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2023 6:29 AM | Sage Therapeutics (Filer)
| Form 424B5 | |
11/07/2023 6:00 AM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023 5:46 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/31/2023 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 7:51 AM | Barrett Elizabeth (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2023 6:49 AM | Sage Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2023 6:20 AM | Sage Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2023 5:45 AM | Sage Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
07/10/2023 7:44 AM | Sage Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2023 7:44 AM | Sage Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
05/11/2023 7:58 AM | Barrett Elizabeth (Reporting) Sage Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |